þ
|
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934, or
|
o
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
DELAWARE
|
|
04-2695240
|
(State or other jurisdiction of incorporation or organization)
|
|
(I.R.S. Employer Identification No.)
|
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MASSACHUSETTS 01752-1234
|
(Address of principal executive offices) (zip code)
|
COMMON STOCK, $.01 PAR VALUE PER SHARE
|
|
NEW YORK STOCK EXCHANGE
|
(Title of each class)
|
|
(Name of exchange on which registered)
|
Large accelerated filer
þ
|
|
Accelerated filer
o
|
|
Non-accelerated filer
o
(Do not check if a smaller reporting company)
|
|
Smaller reporting company
o
|
Exhibit No.
|
Title
|
|
|
|
|
|
|
|
23
|
|
Consent of Independent Registered Public Accounting Firm, Ernst & Young LLP.
|
|
|
|
31.1
|
|
Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
31.2
|
|
Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
|
|
Dated: March 17, 2017
|
|
Boston Scientific Corporation
|
||
|
|
|
|
|
|
|
By:
|
|
/s/ Daniel J. Brennan
|
|
|
|
|
|
|
|
|
|
Daniel J. Brennan
|
|
|
|
|
Executive Vice President and Chief Financial Officer
|
|
|
|
|
(duly authorized officer and principal financial and accounting officer)
|
(1)
|
Registration Statement (Form S-3 Nos. 333-61994, 333-64991 and 333-76346 ) of Boston Scientific Corporation,
|
(2)
|
Registration Statement (Form S-4 Nos. 333-22581 and 333-131608) of Boston Scientific Corporation, and
|
(3)
|
Registration Statement (Form S-8 Nos. 333-25033, 333-25037, 333-36636, 333-61056, 333-61060, 333-76380, 333-98755, 333-111047, 333-131608, 333-133569, 333-134932, 333-151280, 333-174620, 333-174622, 333-188905, and 333-196672) pertaining to the Employees' Savings Plan of Boston Scientific Corporation;
|
1.
|
I have reviewed this Amendment No. 1 to the Annual Report on Form 10-K of Boston Scientific Corporation; and
|
|
|
|
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.
|
Date: March 17, 2017
|
|
/s/ Michael F. Mahoney
|
|
||
|
|
Michael F. Mahoney
|
|
||
|
|
President and Chief Executive Officer
|
|
1.
|
I have reviewed this Amendment No. 1 to the Annual Report on Form 10-K of Boston Scientific Corporation; and
|
|
|
|
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.
|
Date: March 17, 2017
|
|
/s/ Daniel J. Brennan
|
|
||
|
|
Daniel J. Brennan
|
|
||
|
|
Executive Vice President and Chief Financial Officer
|
|